[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV].

MLA

Payan, C., et al. “[Measuring the HIV Viral Load with LCx (Abbott): Importance for the Therapeutic Follow-up of 3 Patients Infected by Type O HIV].” Transfusion Clinique et Biologique : Journal de La Societe Francaise de Transfusion Sanguine, vol. 10, no. 2, Apr. 2003, pp. 72–73. EBSCOhost, https://doi.org/10.1016/s1246-7820(03)00025-9.

APA

Payan, C., Brault, C., Peigne, M., Loison, J., & Chennebault, J.-M. (2003). [Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV]. Transfusion Clinique et Biologique : Journal de La Societe Francaise de Transfusion Sanguine, 10(2), 72–73. https://doi.org/10.1016/s1246-7820(03)00025-9

Chicago

Payan, C, C Brault, M Peigne, J Loison, and J-M Chennebault. 2003. “[Measuring the HIV Viral Load with LCx (Abbott): Importance for the Therapeutic Follow-up of 3 Patients Infected by Type O HIV].” Transfusion Clinique et Biologique : Journal de La Societe Francaise de Transfusion Sanguine 10 (2): 72–73. doi:10.1016/s1246-7820(03)00025-9.